Date: November 18, 2020

Description

Things are going well for your latest drug molecule - it seems efficacious, you have assessed potential toxicity, and even determined a safe starting dose, and now you are ready to move to the clinic. This initiates a number of important development activities requiring intense and thorough research. Drug bioavailability dictates the effective development of formulations including what salts or hydrate forms can be used to optimize solubility, permeability, dissolution rate, etc. Polymorphism provides additional opportunities but certainly complicates research plans. Successful navigation of this phase of drug development requires authoritative and reliable information sources to optimize the speed and efficiency of your research.

SciFindern, the newest and most advanced offering in the SciFinder® family, empowers you to quickly find the most relevant, actionable answers that advance your research forward. Formulus® delivers the world’s largest collection of formulations integrated with authoritative CAS substance, supplier specifications, and regulatory resources serving as a one-stop shop for formulation research .Whether you are using or considering use of these products, this webinar will help improve your search effectiveness, allowing you to save time, be more creative, and increase confidence in your decision making.

In this webinar you will learn how to:

  • effectively search for previously unknown pharmaceutical formulations and understand their use of relevant excipients
  • survey the landscape of pertinent drug delivery systems
  • define the composition, purpose, and physical form of desired pharmaceutical formulations

Times (all times US Eastern Standard Time)

Fuente: CAS, a division of the American Chemical Society

https://www.cas.org/about/events/scifinder-n-webinar111820
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

El Hospital General de València alcanz...

by Hospital General Universitario de Valencia

El Hospital General de València fue el primer hospital público de Es...

Diapositiva de Fotos